The overactivation of mTOR signaling in AD is evidenced by dysregulation of PTEN, Akt, S6K and mTOR itself (Griffin et al., 2005; Rosner et al., 2008; Talbot et al., 2012; Cai et al., 2015). The gene discussed is AKT1; the disease is Alzheimer disease.